ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in Milano, Lombardia

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Allergic Rhinitis
Rhinitis
Lung Diseases
Chronic Obstructive Pulmonary Disease
Disease
Dust Mite Allergy

Asthma trials near Milano, Lombardia, ITA:

REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive Study

study to evaluate the effect of timely treatment with mepolizumab (NUCALA) to achieve clinical remission in adult participants with severe asthma...

Active, not recruiting
Asthma
Other: Spirometry
Drug: Mepolizumab

Phase 4

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Rozzano, Italy and 65 other locations

Self-management strategies for asthma, including patients engagement and adherence to personalised action plans with advice on recognizing a...

Enrolling
Asthma
Other: Optimized self-management of asthma
Other: Conventional self-management of asthma
RESTECH

Pavia, Italy and 8 other locations

Asthma is a chronic condition marked by narrowed and swollen airways due to inflammation leading to recurring symptoms that can vary and wor...

Enrolling
Asthma
Biological: Depemokimab

Phase 3

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Rozzano, Italy and 49 other locations

To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...

Enrolling
Asthma
Biological: Tezepelumab
Other: Placebo

Phase 3

AstraZeneca
AstraZeneca

Pavia, Italy and 142 other locations

to budesonide in children from 6 to less than 12 years of age with asthma.* The study duration will be up to 37 weeks including an investiga...

Enrolling
Asthma
Drug: QMF149
Drug: Budesonide

Phase 3

Novartis
Novartis

Pavia, PV, Italy and 62 other locations

PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition that makes it challenging to breathe, ...

Enrolling
Asthma
Other: Placebo
Drug: PF-07275315

Phase 2

Pfizer
Pfizer

Rozzano, Milano, Italy and 131 other locations

This study evaluates the efficacy and safety of benralizumab as an add-on therapy in uncontrolled eosinophilic asthma participants treated w...

Enrolling
Eosinophilic Asthma
Combination Product: Placebo for Benralizumab
Combination Product: benralizumab

Phase 3

AstraZeneca
AstraZeneca

Milan, Italy and 166 other locations

treatment in children 2 to \<6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze. The study will be conducted i...

Enrolling
Asthma
Wheezing
Drug: Placebo
Drug: Dupilumab

Phase 3

Sanofi
Sanofi

Milan, Lombardy, Italy and 74 other locations

This is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma.The purpose of this...

Active, not recruiting
Asthma
Drug: Budesonide/Albuterol
Drug: Lunsekimig

Phase 2

Sanofi
Sanofi

Milan, Milano, Italy and 238 other locations

with physician-determined surgery-eligible CRSwNP, with or without asthma.Study details include:1. The study duration will be up to 40 weeks...

Active, not recruiting
Chronic Rhinosinusitis With Nasal Polyps
Combination Product: Tezepelumab

Phase 3

AstraZeneca
AstraZeneca

Rozzano, Italy and 40 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems